Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia

Table 2

Clinical status of prostate subjects and benign prostatic hyperplasia subjects.

Items		Prostate cancer	Benign prostatic hyperplasia
Age
	Mean	74.2	71.2
	Range	57-86	52-85
PSA
	<2.5	1	8
	2.5-10	2	15
	10-20	2	8
	20-100	14	0
	>100	12	0
Gleason score
	5	1	N/A
	6	2	N/A
	7	6	N/A
	8	8	N/A
	9	9	N/A
	10	5	N/A